Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2023 Jan 5;23(1):2.
doi: 10.1186/s12879-022-07975-2.

Prevalence of Mycoplasma genitalium and Chlamydia trachomatis in Chinese female with lower reproductive tract infection: a multicenter epidemiological survey

Affiliations
Multicenter Study

Prevalence of Mycoplasma genitalium and Chlamydia trachomatis in Chinese female with lower reproductive tract infection: a multicenter epidemiological survey

Zhan Zhang et al. BMC Infect Dis. .

Abstract

Background: Chlamydia trachomatis and Mycoplasma infections have been regarded as severe challenges to public health worldwide because their potential risk of leading to serious reproductive complications. C. trachomatis is the most common sexually transmitted bacterial infections and the prevalence has been increasing in recent years. As a newly discovered pathogen, Mycoplasma genitalium has gradually been recognized as important sexually transmitted infection and even been called a "new chlamydia". There are no official epidemiological data of M. genitalium in China especially in women with lower reproductive tract infection. This work aims to understand the prevalence and risk factors of M. genitalium and C. trachomatis in women with lower reproductive tract infections and to provide reference for the formulation of health policy in China.

Methods: This study was conducted in the gynecological clinics of 12 hospitals geographically located in different regions in China. Women with purulent cervical secretions or abnormal vaginal microecology were included as the research group, and those with normal vaginal microecology and cervical secretions were included as the control group. A total of 2190 participants were recruited in this project including 1357 of research group and 833 of control group. All participants were required to complete questionnaires, whose vaginal discharge were collected for vaginal microecology test and cervical discharge for detection of M. genitalium and C. trachomatis.

Results: The prevalence of C. trachomatis and M. genitalium were 7.1% (96/1357) and 3.8% (51/1357), respectively in research group. The prevalence of C. trachomatis and M. genitalium varied in different regions. Infection rates of C. trachomatis and M. genitalium were higher in women with abnormal vaginal microecology (C.t P = 0.038, M.g P = 0.043), especially in women with bacterial vaginosis and mixed vaginitis, of which C. trachomatis showed statistical differences (bacterial vaginosis, P = 0.035; mixed vaginitis, P = 0.0001) and M. genitalium was close to statistical differences (bacterial vaginosis, P = 0.057; mixed vaginitis, P = 0.081). Alcoholism and abnormal vaginal microecology were positively correlated with both C. trachomatis and M. genitalium infection. Increasing age, being married and multi-parity were negatively correlated with C. trachomatis infection. There is a positive correlation between multiple sexual partners, diversed styles of sex and C. trachomatis infection.

Conclusions: Women with lower genital dysbiosis have an increased risk of C. trachomatis and M. genitalium. The overall prevalence of M. genitalium is lower than that of C. trachomatis, while they have similarities in the characteristics of infection. Although M. genitalium is not routinely screened as C. trachomatis in young women, attention should be paid to M. genitalium infection in young women with abnormal vaginal microecology or having childbearing needs.

Keywords: Chlamydia trachomatis; Lower reproductive tract infection; Mycoplasma genitalium; Prevalence; Risk factor.

PubMed Disclaimer

Conflict of interest statement

The authors have no competing interests.

Figures

Fig. 1
Fig. 1
Geographical locations of twelve participating hospitals. Areas where these twelve hospitals are located are shown in purple including provinces of Jilin, Beijing, Hebei, Shanxi, Shaanxi, Shandong, Jiangsu, Shanghai, Guangdong and Chongqing etc.
Fig. 2
Fig. 2
Prevalence of C. trachomatis and M. genitalium in each hospitals. Name of hospitals are listed following. 1. Peking University Shenzhen Hospital, 2. Capital Medical University Beijing Obstetrics and Gynecology Hospital, 3. The Second Affiliated Hospital of Hebei Medical University, 4. The Second Hospital of Jilin University, 5. The Second Affiliated Hospital of Shanxi Medical University, 6. Shaanxi Provincial People's Hospital, 7. Obstetrics and Gynecology Hospital of Fudan University, 8. The First Affiliated Hospital of Xi’an Jiaotong University, 9. The Second Hospital of Chongqing Medical University, 10. Nanjing Drum Tower Hospital, 11. Qilu Hospital of Shandong University, 12. Peking University First Hospital

Similar articles

Cited by

References

    1. Centers for Disease Control and Prevention. Sexually Transmitted Disease Surveillance 2020.Atlanta: U.S. Department of Health and Human Services; 2022.
    1. Owusu-Edusei K, Chesson HW, Gift TL, Tao G, Mahajan R, Ocfemia MC, Kent CK. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis. 2013;40(3):197–201. doi: 10.1097/OLQ.0b013e318285c6d2. - DOI - PubMed
    1. Tang W, Mao J, Li KT, Walker JS, Chou R, Fu R, Chen W, Darville T, Klausner J, Tucker JD. Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: a global systematic review and meta-analysis. Sex Transm Infect. 2020;96(5):322–329. doi: 10.1136/sextrans-2019-053999. - DOI - PMC - PubMed
    1. Workowski KA, Bolan GA. Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. 2015;64(RR-03):1–137. - PMC - PubMed
    1. Workowski KA, Bachmann LH, Chan PA, Johnston CM, Muzny CA, Park I, Reno H, Zenilman JM, Bolan GA. Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187. doi: 10.15585/mmwr.rr7004a1. - DOI - PMC - PubMed

Publication types